BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Mergers and Acquisitions (World)
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal 9/12/2014
ReproCELL Acquires The iPS Cell Business Unit Of Stemgent, Inc. 9/9/2014
Cellectis (ALCLS) Announces The Closing Of The Sale Of Its Swedish Subsidiary Cellectis AB To Takara Bio 9/4/2014
China Biologic Products Completes Transaction To Acquire Additional Equity Stake In Guizhou Taibang 9/4/2014
Mercachem To Acquire Prague Business From Synthon 9/3/2014
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer (PFE) Bid; Start Of New Cancer Trial 9/2/2014
Luye Pharma Buys Majority Stake In Beijing Jialin For $599 Million 8/29/2014
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion 8/29/2014
Synexus Further Expands Its Global Footprint With An Acquisition In South Africa 8/27/2014
Novo Nordisk A/S (NVO) Prefers To Grow On Its Own, Not Buy Others: CEO 8/27/2014
Disappointment Looms As Roche (RHHBY) Drops Plans To Bid For The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) 8/26/2014
Roche (RHHBY) Pays $8.3 Billion For Bay Area's InterMune, Inc. (ITMN), Pledges To Keep Employees 8/26/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Pfizer (PFE) Eyes Possible Actavis (ACT) Bid Whilst Weighing Next Steps Over AstraZeneca PLC (AZN) 8/22/2014
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio 8/22/2014
DrugDev Acquires Award-Winning Trialnetworks Platform, Launches Innovation Lab, Unveils Investigator Databank Website And Reaches $1 Billion In Global Site Payments In First Half Of 2014 8/21/2014
Sweden's Recipharm AB Pays $160 Million For Corvette Pharmaceutical Services Group 8/19/2014
Confirmed: Novartis AG (NVS) To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal 8/19/2014
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks 8/19/2014
Deal Is Back On: Novartis AG (NVS) To Invest Heavily In Gamida Cell Ltd. Before Acquisition 8/18/2014
InterMune, Inc. (ITMN) Goes Up On The Block; GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (France) (SAN.PA) Line Up 8/18/2014
Mallinckrodt Pharmaceuticals (MNK) Completes Acquisition Of Questcor Pharmaceuticals, Inc. (QCOR) 8/15/2014
Roche (RHHBY) May Gobble Up The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) For $10 Billion 8/15/2014
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation 8/14/2014
Merck KGaA (MKGAF.PK) CEO Eyes Interesting Takeover Targets 8/14/2014
SkyePharma Inc. (SKYE) Acquires A Novel Inhaled Therapy Platform 8/13/2014
uniQure Acquires Cardiology Gene Therapy Company InoCard 8/12/2014
Boehringer Ingelheim Vetmedica, Inc. Acquires Licensing Rights For Artilysin® Technology From Lysando AG 8/12/2014
Endo International plc (ENDP) Completes Acquisition Of DAVA Pharmaceuticals 8/7/2014
After Layoff News, Novartis AG (NVS)'s New York Campus Officially Goes On The Market 8/7/2014
AstraZeneca PLC (AZN), Shire Slip As The U.S. Looks To Stop Tax Inversion Deals 8/7/2014
Analysts Believe Vulnerable GlaxoSmithKline (GSK) May Be Pfizer (PFE)'s Plan B 8/6/2014
Roche (RHHBY) Bags Santaris Pharma A/S In Deal Worth $450 Million 8/5/2014
Private Equity Firms Mull $10 Billion Merger Of Older GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Brands 8/4/2014
Hedge Funds Bet AstraZeneca PLC (AZN) Will Stay Independent For A Little While Longer 8/4/2014
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse 7/31/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 7/31/2014
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion 7/30/2014
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions 7/30/2014
Cellectis (ALCLS) Sells Its Swedish Unit To Takara Bio For Undisclosed Amount 7/29/2014
AbbVie (ABBV) Trod Cautiously In Inversion Takeover Bid To Woo Drug Maker Shire 7/25/2014
Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site 7/24/2014
Stallergenes, S.A. (GENP.PA) Expands Latin American Presence With Acquisition Of Alergo Pharma S.R.L. In Argentina 7/21/2014
Roche (RHHBY) CEO Plans To Steer Clear Of Big Acquisitions 7/21/2014
Novartis AG (NVS), BWK Sell Stakes In Patch Maker LTS Lohmann Therapie-Systeme AG, Pockets $400 Million From Sale 7/17/2014
Sanofi (France) (SAN.PA) Quietly Held Talks With Abbott Laboratories (ABT), Mylan Inc. (MYL) About Mature Drugs 7/17/2014
Yibai Pharma To Acquire Horus C&K Pharma For $128 Million 7/16/2014
Chiltern Acquires Ockham And The Companies Merge Operations 7/15/2014
Phlexglobal Announces Acquisition By Bridgepoint Development Capital 7/15/2014
Hikma Pharmaceuticals Completes The Acquisition Of Assets Of Bedford Laboratories 7/15/2014
BioTie Therapies Corp. Will Not Exercise Option To Buy Neurelis, Neurelis Regains Rights To Intranasal Diazepam Program 7/11/2014
Valeant Pharmaceuticals International (VRX) Completes Sale Of Filler And Toxin Assets To Galderma 7/10/2014
AbbVie (ABBV) Forced To Retract Claims Of Shire Investor Support 7/9/2014
Salix Pharmaceuticals, Ltd. (SLXP) Scoops Up Cosmo Technologies For Tax Savings 7/9/2014
$100 Million Triple Life Sciences Deal For Newly Formed Concept Life Sciences 7/8/2014
AbbVie (ABBV)'s Battle For Shire: Why This Time It's Different 7/8/2014
Valeant Pharmaceuticals International (VRX) Completes Acquisition Of PreCision Dermatology 7/8/2014
Xellia Pharmaceuticals Expands Into The U.S. With Manufacturing Plant Buy 7/7/2014
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/3/2014
Medicure Inc. (MCU) Grabs Minority Position In Pharmaceutical Manufacturer, Apicore LLC 7/3/2014
NicOx SA (COX.PA) Scoops Up Aciex Therapeutics In $120 Million Deal 7/2/2014
Cell Source Inc. Announces Acquisition And $3.6 Million Private Placement To Advance Novel Cancer Therapies 7/1/2014
AbbVie (ABBV) Takes Shire Courtship Trip To London 6/30/2014
Merz North America Pays $600 Million For Ultrasound Facelift Company Ulthera 6/30/2014
RedHill Biopharma Ltd. (RDHL) Acquires Phase 2 Oncology Drug MESUPRON® From Wilex AG (WL6.DE) 6/30/2014
Shire Entertained Many "Large Opportunities" Before AbbVie (ABBV) Bid 6/27/2014
Like GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Mulls Sale Of Older Drugs, Plans To Put Dengue Vaccine Program In Separate Unit 6/27/2014
AbbVie (ABBV) Urges Talks With Shire, May Have To Raise Bid To $51 Billion 6/25/2014
Valeant Pharmaceuticals International (VRX) Files Preliminary Proxy Statement For Special Meeting Of Shareholders To Approve Share Issuance In Proposed Acquisition Of Allergan Inc. (AGN) 6/25/2014
Warnex Inc. (CC:WNX) Received TSX-V Approval And Waives Due Diligence Condition To Amalgamation With Diagnos Inc. (ADK) 6/25/2014
Shire To Set Out AstraZeneca PLC (AZN)-Style Defense Against AbbVie (ABBV)'s $46 Billion Bid 6/24/2014
Endo Buys DAVA Pharmaceuticals For $575 Million 6/24/2014
H. Lundbeck A/S (LUN.CO) Completes Acquisition Of Chelsea Therapeutics, Inc. (CHTP) 6/24/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Tentative Election Deadline Of June 27, 2014 6/24/2014
Abbott Laboratories (ABT) Scoops Up Russian Drugmaker Veropharm For Between $395 To $495 Million Cash 6/24/2014
AbbVie (ABBV) Release: Shire Bid Could Move A Lot High Risk Puts Ceiling At £55/Share 6/23/2014
Lundbeck Inc. (LUN.CO) Successfully Completes Tender Offer For Chelsea Therapeutics, Inc. (CHTP) 6/23/2014
Shire plc Release: Management Spurns Three Offers From AbbVie (ABBV) , Fighting For Irish Independence, Call Monday Morning 6/23/2014
To Fend Off Pfizer Inc. (PFE), AstraZeneca PLC (AZN) Contemplating Sale Of Some Future Revenue From Existing Drugs 6/23/2014
Third Time Is Not The Charm As AbbVie (ABBV)'s $46 Billion Bid For Irish Rival Shire Rejected 6/23/2014
Rumor: Pfizer Inc. (PFE) May Be Interested In Buying Bristol-Myers Squibb Company (BMY) After Losing AstraZeneca PLC (AZN) 6/20/2014
While Valeant Pharmaceuticals International (VRX) Fights For Allergan Inc. (AGN), Allergan Takeover Bid For Shire "Imminent" 6/19/2014
New Drugs To Help Maintain Independence, Ward Off M&A Prospects: Actelion Ltd. (ALIOF.PK) CEO 6/19/2014
Trendlines Acquires Intellectual Property From Collaboration With Endo 6/18/2014
Irish-Based Shire Braces For Takeover Bids 6/18/2014
Pfizer Inc. (PFE) CFO Reveals Money Killed AstraZeneca PLC (AZN) Deal 6/16/2014
Commentary: BioSpace (DHX) Readers Sound Off On Big Pharma Takeovers 6/12/2014
Roche (RHHBY) Markets 5 Buildings On New Jersey Campus, Razing The Rest 6/11/2014
Chelsea Therapeutics, Inc. (CHTP) Announces The Expiration Of The Hart-Scott-Rodino Waiting Period In Relation To The Proposed Acquisition Of Chelsea Therapeutics By H. Lundbeck A/S (LUN.CO) 6/6/2014
Teva Pharmaceutical Industries Limited (TEVA) Buys Privately Held Labrys Biologics In Deal Worth $825 Million 6/4/2014
GlaxoSmithKline (GSK) Hunts For Suitors To Buy Older Drugs, Eyes Cash To Focus On Most Lucrative Areas Of Business 6/2/2014
Endo Completes Sale Of Early Stage Drug Discovery Portfolio 6/2/2014
TiGenix Completes The Sale Of Its Dutch Manufacturing Facility To PharmaCell BV 6/2/2014
Provence Technologies Acquires Synprosis 6/2/2014
Pfizer Inc. (PFE) Officially Ditches Pursuit Of AstraZeneca PLC (AZN) 5/29/2014
Sweden's Lund University Acquires Biomass Pretreatment Reactor From AdvanceBio Systems 5/27/2014
Recordati S.p.A Finalizes The Second Tranche Of Its Acquisition Of Opalia Pharma In Tunisia 5/27/2014
Loophole Offers Pfizer Inc. (PFE) A Risky Way Back Into A Deal With AstraZeneca PLC (AZN) 5/23/2014
H. Lundbeck A/S (LUN.CO) Commences Tender Offer For All Outstanding Shares Of Chelsea Therapeutics, Inc. (CHTP) 5/23/2014
BioAlliance Pharma, TopoTarget A/S To Merge, Combined Entity To Be Named Onxeo 5/22/2014
Clarification Regarding Pfizer Inc. (PFE) Statement 5/21/2014
AstraZeneca PLC (AZN) Rejects Pfizer Inc. (PFE)'s Final Offer 5/20/2014
Endo Completes Acquisition Of Rights To Sumavel® DosePro® 5/19/2014
Boston Scientific Corporation (BSX) Pays $415 Million For Bayer AG (BAYZF) Unit 5/19/2014
Abbott Laboratories (ABT) Expands Latin American Presence And Branded Generics Portfolio With Acquisition Of CFR Pharmaceuticals 5/16/2014
Pfizer Inc. (PFE) Exec Claims AstraZeneca PLC (AZN) Deal Will Not Put Lives At Risk 5/15/2014
AstraZeneca PLC (AZN) Leaves Door Ajar To Pfizer Inc. (PFE), Despite Hurdles 5/15/2014
Eurofins Shells Out $255 Million For U.S. Diagnostic Testing Company 5/14/2014
Origin Agritech Limited (SEED) Announces Receipt Of Acquisition Proposal 5/13/2014
Pfizer Inc. (PFE) Presses AstraZeneca PLC (AZN) Case As CEO Faces UK Grilling 5/13/2014
Shire Pharmaceuticals (SHPG) To Acquire Lumena Pharmaceuticals For Upfront Payment Of $260 Million In Cash 5/13/2014
Merck & Co., Inc. (MRK) Signs Sale Agreement With Santen Pharmaceutical For Merck's Ophthalmology Products In Japan And Key Markets In Europe And Asia Pacific 5/13/2014
Pfizer Inc. (PFE)'s Bid For AstraZeneca PLC (AZN) Shows That Big Pharma Is As Rotten As The Banks 5/13/2014
Merck KGaA (MKGAF.PK) Invests In Innovations For Future Growth 5/12/2014
Mallinckrodt Pharmaceuticals (MNK) And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Announce Early Termination Of HSR Act Waiting Period 5/12/2014
Lundbeck Inc. (LUN.CO) Swallows Up Chelsea Therapeutics, Inc. (CHTP) In Deal Worth $658 Million 5/9/2014
Taking A Swipe At Mylan Inc. (MYL), MEDA Preys On Its Own M&A Opportunities 5/8/2014
AstraZeneca PLC (AZN) Shares Back On Rise Amid Fresh Bid Speculation 5/8/2014
Despite Repeated Rebuffs, Teva Pharmaceutical Industries Limited (TEVA) Woos Cipla Ltd. With $6 Billion Offer 5/8/2014
Pfizer Inc. (PFE) Execs Claim AstraZeneca PLC (AZN) Takeover Could Improve R&D 5/7/2014
Pfizer Inc. (PFE) Hints At Potential Hostile Move For AstraZeneca PLC (AZN) 5/7/2014
Merck & Co., Inc. (MRK) May Use Bayer AG (BAYZF) Cash To Hunt For Companies With Promising Experimental Drugs 5/7/2014
Bayer AG (BAYZF) Finally Bags Merck & Co., Inc. (MRK)'s Consumer Biz For $14.2 Billion 5/7/2014
FORMA Therapeutics, Inc. Acquires Covalent Chemistry Platform From Netherlands Cancer Institute (NCI) 5/5/2014
Novartis AG (NVS) Abandons $600 Million Purchase Of Gamida Cell Ltd. 5/5/2014
AstraZeneca PLC (AZN) Calls Pfizer Inc. (PFE) Takeover Bid "Inadequate," Nixes Sweetened $106 Billion Offer 5/5/2014
Shire Pockets A Promising Pipeline In $75 Million Plus Fibrotech Buyout Deal 5/2/2014
Reckitt Benckiser Plc (RB.L) Says No Longer In Talks With Merck & Co., Inc. (MRK) 5/1/2014
Amgen (AMGN), AbbVie (ABBV) Seen As Possible White Knights For AstraZeneca PLC (AZN) 5/1/2014
Bayer AG (BAYZF) Offers To Swap Animal Health Unit, Cash For Merck & Co., Inc. (MRK)'s $14 Billion OTC Unit 5/1/2014
GlaxoSmithKline (GSK) Distances Itself From Bid For Rival AstraZeneca PLC (AZN) 5/1/2014
Sanofi (France) (SAN.PA) Explores $7 Billion-Plus Sale Of Mature Drug Portfolio Amid Pharma M&A Resurgence 5/1/2014
Bayer AG (BAYZF) May Sell $10 Billion Plastics Unit To Focus On Health 4/30/2014
Healthcap IV Is Committed To Vote In Support Of TopoTarget A/S’s Proposed Merger With BioAlliance Pharma 4/29/2014
Allergan Inc. (AGN) Contacts Sanofi (France) (SAN.PA), Johnson & Johnson (JNJ) To See If They Are Interested 4/29/2014
Mylan Inc. (MYL) Can't Take Hint, Meda AB (MEDA-A.ST) Rejects Second Takeover Offer 4/28/2014
Zogenix, Inc. (ZGNX) Unloads Sumavel® DosePro® To Endo For $85 Million Cash 4/24/2014
AstraZeneca PLC (AZN) Finally Rids Delaware Site For Approximately $44 Million 4/23/2014
GlaxoSmithKline (GSK) Pays $7.1 Billion For Novartis AG (NVS)'s Vaccine Business 4/22/2014
Beckman Coulter, Inc. (BEC) Buys Xitogen Of Suzhou 4/22/2014
Pfizer Inc. (PFE) Cautiously Approaches Strained AstraZeneca PLC (AZN) With $101 Billion Buyout Deal 4/22/2014
Fosun Pharma Ups Offer For Healthcare Chain Chindex International, Inc. (CHDX) From $369 Million To $461 Million 4/21/2014
Chindex International, Inc. (CHDX) Agrees To Higher $24/Share Bid From Insiders 4/21/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Receive Federal Trade Commission Second Request Under Hart-Scott-Rodino 4/18/2014
GlaxoSmithKline (GSK) To Unload 60-Acre Property In India 4/18/2014
BioAlliance Pharma And TopoTarget A/S To Merge To Form Orphan Oncology Powerhouse 4/16/2014
Novartis AG (NVS) Overtakes Pfizer Inc. (PFE) As Top Drug Company 4/16/2014
Novartis AG (NVS), Shire Weighing $1.3 Billion Offer For ThromboGenics NV (TBGNF) 4/15/2014
Chindex International, Inc. (CHDX) Announces Higher $23/Share Takeover Offer 4/14/2014
Novartis AG (NVS) To Sell Off Land For Homes While Exploring Options For Future Science Or Business Park 4/11/2014
Royal DSM In Exclusive Discussions To Acquire Aland (China) 4/9/2014
Zhejiang Conba Pays $160.5 Million For Majority Stake In Baite Pharma 4/9/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Plans To Gradually Phase-Out Of Ranbaxy Laboratories (RANBAXY.BO)-Branded Drugs In U.S. 4/9/2014
Meda AB (MEDA-A.ST), Valeant Pharmaceuticals International (VRX) Terminate Joint Ventures 4/7/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) To Buy Struggling Ranbaxy Laboratories (RANBAXY.BO) In $3.2-Billion Landmark Transaction 4/7/2014
Roche (RHHBY) Buys Rights To ORYZON Genomics's Cancer-Suppressing Gene Drug In $521 Million+ Deal 4/7/2014
Mylan Inc. (MYL) Rumored To Be Considering Bid For Swedish Pharm Rival Meda AB (MEDA-A.ST), Meda Shares Halted 4/4/2014
Like GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Eyes More Acquisitions, Sees Growth In Africa 4/3/2014
Charles River Laboratories (Massachusetts) And Galapagos NV (GLPG.BR) Complete Transaction 4/1/2014
PPF Group Expands In The Field Of Biotechnology And Immunotherapy 4/1/2014
Actavis (ACT) Bets $100 Million Cash OnThai Pharmaceutical Silom Medical 4/1/2014
ADI: Proposed Acquisition Of Tiziana Pharma Limited 3/31/2014
ICON Scoops Up Medical Device Firm Aptiv Solutions For $143.5 Million Cash 3/31/2014
Lupin Ltd. (LUPN.BO) Buys Mexican Drugmaker Laboratorios Grin S.A. De C.V. For Undisclosed Sum 3/28/2014
AstraZeneca PLC (AZN) Takes Full Control Of Japanese Unit, Buys Out Sumitomo Chemical Company, Ltd. For $102 Million 3/26/2014
Sanofi (France) (SAN.PA) Rumored To Join Bidders For Merck & Co., Inc. (MRK)'s Consumer Unit 3/25/2014
Evotec AG (EVTG.F) Acquires Bionamics GmbH To Accelerate "EVT Innovate" Strategy 3/24/2014
Horizon Pharma Scoops Up Vidara Therapeutics In $660 Million Buyout Move, Will Become Horizon Pharma plc.  (HZNP) 3/19/2014
Mallinckrodt Pharmaceuticals (MNK) Completes $1.4 Billion Acquisition Of Cadence Pharmaceuticals, Inc. 3/19/2014
Proteon Therapeutics, Inc., Looking Past Ill-Fated Novartis AG (NVS) Deal, Goes It Alone 3/18/2014
Gamida Cell Ltd. Gets Hefty Buyout Offer From Unknown Global Pharma Co., Is It Novartis AG (NVS)? 3/18/2014
Vectura Limited Pays A Whopping $181 Million For Activaero 3/13/2014
AstraZeneca PLC (AZN) To Sell UK Research Site, Record Charge Of $275 Million 3/12/2014
GlaxoSmithKline (GSK) Ponies Up $1 Billion To Lift Indian Stake To 75 Percent 3/10/2014
Kemira Oyj Completes The Divestment Of Chemsolutions' Formic Acid Business 3/6/2014
Debiopharm To Acquire Products Or Companies To Expand Activities At Manufacturing Facility In Martigny (Valais, Switzerland) 3/6/2014
Advanced Accelerator Applications Enters UK And Irish Nuclear Medicine Markets With The Acquisition Of Imaging Equipment Ltd 3/4/2014
Shyndec (600420.SS) Pays $49 Million For 30% Of Rongsheng Pharma 3/3/2014
Novartis AG (NVS) Chairman Rules Out Merger With Roche (RHHBY) 3/3/2014
Endo Health Solutions Inc. (ENDP) Completes Acquisition Of Paladin Labs Inc. (CC:PLB) 2/28/2014
BioTie Therapies Corp. Updates Outlook: Intends To Develop SYN120 Internally And Will Not Exercise Its Option To Acquire Neurelis Until Further Notice 2/28/2014
Shanxi Taxus Pharma Plans To Acquire California Pharma 2/28/2014
Perrigo Company (PRGO) Scoops Up Basket Of Value-Brand OTC Drugs For $51 Million Cash 2/28/2014
Watson-Marlow Pumps Group Acquires Bio Pure Technology Limited 2/27/2014
Bayer AG (BAYN.DE) Buys Dihon Pharmaceutical Group For About $680 Million To Add Traditional Chinese Medicine To Product Line 2/27/2014
Pfizer Inc. (PFE) Reveals Internal Restructuring Plans 2/27/2014
Rumor: AstraZeneca PLC (AZN) Actively Pursued Forest Laboratories, Inc. (FRX) 2/26/2014
Eli Lilly and Company (LLY) To Buy German Poultry Vaccine Maker For Undisclosed Amount 2/25/2014
Bayer AG (BAYN.DE) Clinches $2.9 Billion Deal For Norway's Algeta 2/24/2014
Andromeda Biotech Acquires DiaPep277 Rights From Teva Pharmaceutical Industries Limited (TEVA) 2/24/2014
Week in Review: Fosun Pharma And TPG Offer $369 Million For Chindex International, Inc. (CHDX) 2/24/2014
Shuanglong Tonghua Chemical Co., Ltd Acquires Jinbao Pharma For $178 Million 2/24/2014
Harbin Gloria Pharmaceuticals (002437.SZ) In $170 Million Deal To Acquire Huatuo Medical Science 2/24/2014
Teva Pharmaceutical Industries Limited (TEVA) Advances Amid Takeover Prospects 2/24/2014
Jazz Pharmaceuticals plc (JAZZ) Completes Tender Offer For Gentium S.p.A. Shares 2/21/2014
Merck KGaA (MKGAF.PK) Has Cash Ready To Pursue A Takeover Worth Billions: CEO 2/21/2014
Actavis (ACT)' Acquisition Of Forest Laboratories, Inc. (FRX) Will Expand Its Branded Drug Portfolio And Facilitate Long-Term Growth, Says Globaldata Analyst 2/20/2014
Actavis (ACT) Bags Rival, Forest Laboratories, Inc. (FRX), For $25 Billion; Forest Stock Rockets +27.52% At Market Close (February 18, 2014) 2/19/2014
Fosun Pharma, TPG Scoop Up US-Listed Chinese Healthcare Firm Chindex International, Inc. (CHDX) In $369 Million Deal 2/18/2014
Endo Health Solutions Inc. (ENDP) Announces South African Competition Act Compliance And Approval Under The Investment Canada Act In Connection With Its Proposed Acquisition Of Paladin Labs Inc. (CC:PLB) 2/18/2014